News
4317 posts · page 84 of 180
FDA Approvals Post-Cures Act: A Decline in Study Requirements
The 21st Century Cures Act has streamlined FDA approval processes, reducing the number of studies required for new drugs.
Anavex Life Sciences Posts $7.8M Net Income in Q3 FY2026
Anavex Life Sciences reported a $7.8 million net income for Q3 FY2026, with cash reserves at $118.3 million.
New Pediatric Cell and Gene Therapies: Clinical Insights
Recent approvals in cell and gene therapies offer new clinical insights for pediatric treatments, enhancing therapeutic options for young patients.
Boston Scientific Cyberattack Disrupts Global Operations
Boston Scientific faces operational disruptions after a cyberattack. Investigation is ongoing, with recovery efforts underway.
FDA Approves Rasonque for Advanced Pancreatic Cancer
The FDA has approved Rasonque, a drug that doubles survival for advanced pancreatic cancer patients.
Infant Among Two Measles Deaths in Pennsylvania, First in 35 Years
Pennsylvania reports its first measles-related deaths in 35 years, including an infant, amid concerns over vaccination rates.
HepaRegeniX's Darizmetinib Gains Orphan Drug Status in Liver Treatment
HepaRegeniX secures orphan drug designation for Darizmetinib, targeting post-hepatectomy liver failure.
Benjamin Diamond Secures Grant for Innovative Myeloma Genomic Research
Benjamin Diamond receives funding to advance plasma-based genomic sequencing for multiple myeloma, promising new insights.
Rapid Genome Sequencing Enters PICU, Reshaping Pediatric Care
Whole-genome sequencing is moving from research to PICU, promising faster diagnoses. Sponsors must navigate new challenges.
Citywide Rapid Genome Sequencing Transforms Pediatric Critical Care
A San Diego initiative uses rapid genome sequencing to improve outcomes for critically ill children.
Indian Scientists Achieve Breakthrough in Gene-Editing Peas
Researchers in India have overcome a major challenge in gene-editing peas, potentially improving crop quality and yield.
Ultrasound: A New Avenue in Gene Therapy Delivery
Ultrasound technology could revolutionize gene therapy by overcoming delivery challenges.
AI-Driven Genome Editors Revolutionize Plant Research at ICAR-CRRI
ICAR-CRRI in Cuttack pioneers AI-designed genome editors to enhance plant research, marking a key advance in agricultural innovation.
Infant Among Two Measles Deaths in Pennsylvania Amid Outbreak
Pennsylvania reports its first measles deaths in 35 years, including an infant, amid a significant outbreak.
Antibody–Drug Conjugate Safety: Tackling Toxicities by 2026
New strategies for managing antibody-drug conjugate toxicities aim to enhance patient safety by 2026, focusing on improved mechanisms and monitoring.
Innovative Drug Delivery Method Enhances Cancer Treatment Precision
A new binding-to-release strategy offers targeted drug delivery, potentially improving cancer treatment efficacy.
Thymus Risks in NSCLC Radiotherapy Highlighted
Radiotherapy for NSCLC may harm the thymus, sparking concerns about immune function.
Thymus Health Gains Attention in Radiotherapy Strategies
New research highlights the importance of considering thymic health in radiotherapy planning to enhance patient outcomes.
Thymus-Sparing Strategies Gain Attention in NSCLC Radiotherapy
Experts suggest considering thymus-sparing techniques in NSCLC radiotherapy to minimize immune system impact.
Indian Scientists Develop 'Smart' Drug to Potentially Replace Chemotherapy
A new 'smart' cancer drug by Indian scientists could revolutionize cancer treatment by offering an alternative to chemotherapy.
FDA Greenlights Ziihera® for HER2+ Gastroesophageal Cancer Treatment
Ziihera® (zanidatamab-hrii) gains FDA approval for use with or without Tislelizumab in first-line treatment of HER2+ advanced gastroesophageal adenocarcinoma.
Ivonescimab Outperforms Durvalumab in Advanced Biliary Tract Cancer Trial
Akeso's trial in China shows ivonescimab with chemotherapy boosts survival over durvalumab for advanced biliary tract cancer.
FDA Greenlights Daraxonrasib: New Hope for Pancreatic Cancer Patients
The FDA has approved Daraxonrasib, a new drug targeting KRAS mutations, doubling survival time for pancreatic cancer patients.
FDA Approves Revolution Medicines' Rasonque for Pancreatic Cancer
The FDA has approved Rasonque, a new drug offering hope for advanced pancreatic cancer patients.